The TransEuro open-label trial of human fetal ventral mesencephalic transplantation in patients with moderate Parkinson’s disease
Roger A. Barker(University of Cambridge), Olle Lindvall(Lund University), Sam Hewitt(Wellcome/MRC Cambridge Stem Cell Institute), Ruwani Wijeyekoon(Wellcome/MRC Cambridge Stem Cell Institute), Gesine Paul(Skåne University Hospital), Rachel Hills(Cardiff University), Victoria H. Roberton(Cardiff University), Kathryn J. Peall(Children's Hospital at Westmead), Stanley E. Lazic(Prioris.ai (Canada)), Eduardo M. Torres(University of Massachusetts Chan Medical School), Debbie Williams(Cardiff University), Mariah J. Lelos(Cardiff University), Thomas Foltynie(National Hospital for Neurology and Neurosurgery), Paola Piccini(Hammersmith Hospital), Tagore Nakornchai(Wellcome/MRC Cambridge Stem Cell Institute), Viswas Dayal(University College London), Sarah A. Moore(Dalhousie University), Krista Sibley(University College London), Stephen B. Dunnett(Cardiff University), Dilan Athauda(The Francis Crick Institute), Emma Cutting(Wellcome/MRC Cambridge Stem Cell Institute), Anders Björklund(Lund University), Anne Rosser(Cardiff University), Adriana Roca‐Fernández(Hammersmith Hospital), Anne-Marie McGorrian(Cardiff University), Claire Kelly(Cardiff University), Naomi Hannaway(Hammersmith Hospital), Antonio Martín‐Bastida(Hammersmith Hospital), Caroline Scherf(Cardiff University), K.L. Shires(Cardiff University), Andreas–Antonios Roussakis(Hammersmith Hospital), Alistair Church(Cardiff University), Shane Grealish(Skåne University Hospital), Nicholas P Lao–Kaim(Hammersmith Hospital), Xiaoling He(Wellcome/MRC Cambridge Stem Cell Institute), Danielle Daft(Wellcome/MRC Cambridge Stem Cell Institute), Harry Bulstrode(Wellcome/MRC Cambridge Stem Cell Institute), Krista Farrell(Wellcome/MRC Cambridge Stem Cell Institute), Hjálmar Bjartmarz(Skåne University Hospital), Philipp Mahlknecht(University College London), Jenny Nelander-Wahlestedt(Skåne University Hospital), Robert C. Morris(Wellcome/MRC Cambridge Stem Cell Institute), Pamela Tyers(Wellcome/MRC Cambridge Stem Cell Institute), Ngoc Nga Vinh(Cardiff University), Natalie Valle Guzman(Wellcome/MRC Cambridge Stem Cell Institute), Caroline Williams-Gray(Wellcome/MRC Cambridge Stem Cell Institute), Zinovia Kefalopoulou(University College London), Linnea Roupé(Skåne University Hospital), Amy Evans(Wellcome/MRC Cambridge Stem Cell Institute)
Cited by 15